The Daily Cardinal5d
Study at UW-Madison brings possible placenta treatment closer to clinical trials
Researchers from the University of Wisconsin-Madison and the University of Florida have discovered a treatment for placentas ...
PipelineReview.com4d
China’s First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease
SAN FRANCISCO, CA, USA and SUZHOU, China I March 14, 2025 I Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company ...
Medindia5d
China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME for the Treatment of Thyroid Eye Disease
("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and ...